Bandaram Pharma Packtech Hits New 52-Week Low at Rs. 24

Bandaram Pharma Packtech has reached a new 52-week low, hitting Rs. 24 today, marking a significant downturn for the microcap healthcare services company. This decline comes as the stock has underperformed its sector by 3.68% and has seen a consecutive fall over the past two days, resulting in a total drop of 3.92% during this period.
The company's performance over the past year has been notably challenging, with a staggering decline of 52.90%, contrasting sharply with the Sensex's positive performance of 5.68% in the same timeframe. Bandaram Pharma is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend.

Financial metrics reveal a weak long-term fundamental strength, highlighted by an average Return on Capital Employed (ROCE) of just 5.74% and a high Debt to EBITDA ratio of 6.31 times, suggesting difficulties in servicing debt. The company's recent quarterly results also reflect a decline in net sales, which fell by 28.76%, further emphasizing the challenges faced by Bandaram Pharma Packtech in the current market environment.